Pfizer Spinoff Zoetis Takes Pershing Square's Doyle Onto Board
Zoetis, an animal health company spun off from Pfizer in 2013, is taking a representative from Bill Ackman's hedge fund Pershing Square Capital Management onto its board of directors...
Related Articles
- DuPont's Activist Response Has Perfect Formula To Counter Trian's Nelson Peltz also written by Antoine Gara
- Airbnb Adds Outgoing American Express CEO Kenneth Chenault To Board of Directors also categorized in BoardMoves
- What Lies Ahead For Chesapeake As McClendon Exits? also categorized in BoardMoves
- Ackman Expects 'Influence' in Air Products CEO Search also written by Antoine Gara
- Tempur Sealy Settles With Hedge Fund H Partners After CEO Ouster also written by Antoine Gara
- Getting Gen-Y on Boards (of Directors) also published in forbes.com
- Berkshire Hathaway Wannabe Turning Into A Quagmire For Investors also written by Antoine Gara
- Cloud Foundry Board Elects EMC CTO As Chair also categorized in BoardMoves
- Intel CEO to retire as chipmaker struggles with mobile also categorized in BoardMoves
- Comcast Boosts Stock Buyback Nearly 60% After Time Warner Cable Deal Bust also written by Antoine Gara
Login to comment.